Presentation TCT 2023

PROs are a Powerful Endpoint in TR Interventional Trials

Presenter: Suzanne Arnold

October 25, 2023

REGISTER for free or LOG IN to view this content

PROs are a Powerful Endpoint in TR Interventional Trials

Structural Heart

TCT 2023

Tricuspid Valve

Up Next

Presentation TCT 2023

PROs Alone in Non-Blinded Studies Shouldn’t Drive Device Approval

Presenter: Nir Uriel

October 25, 2023

More slides +

Presentation TCT 2023

Intentional Coronary Revascularization Versus Conservative Therapy in Patients, who Underwent Successful Peripheral Artery Revascularization due to Critical Limb Ischemia - the INCORPORATE Randomized Clinical Trial

Presenter: Gabor Toth

October 25, 2023

Presentation TCT 2023

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Presenter: Eric Secemsky

October 25, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.